brukinsa (zanubrutinib) has been approved for cll/sll!
Published 1 year ago • 494 plays • Length 0:35Download video MP4
Download video MP3
Similar videos
-
6:45
zanubrutinib demonstrates superior pfs compared with ibrutinib for treatment of r/r cll and sll
-
5:00
beigene’s brukinsa (zanubrutinib): a newly approved treatment medicine for mantle cell lymphoma (mcl
-
2:07
sequoia: zanubrutinib vs br in treatment-naïve cll/sll
-
4:14
zanubrutinib improves pfs compared to ibrutinib for r/r cll and small lymphocytic lymphoma
-
5:44
ash 2022: zanubrutinib demonstrates superior pfs compared with ibrutinib for r/r cll/sll: result...
-
3:31
tolerability of next-generation btk inhibitors: acalabrutinib, zanubrutinib and pirtobrutinib
-
2:26
the value of zanubrutinib in the cll treatment armamentarium & sequoia trial updates
-
5:23
constantine tam: zanubrutinib active in treatment-naïve cll/sll
-
0:58
what is your preferred btk inhibitor in cll?
-
7:03
brukinsa® (zanubrutinib) efficacy in high-risk cll patients with dr anthony nguyen
-
2:04
updated long-term follow-up of sequoia: zanubrutinib vs bendamustine-rituximab in untreated cll/sll
-
1:22
dr. leslie on sequencing zanubrutinib in mcl
-
6:35
efficacy and safety of acalabrutinib vs. zanubrutinib for cll (chronic lymphocytic leukemia)
-
1:05
final analysis of the alpine trial: zanubrutinib vs ibrutinib in r/r cll
-
1:05
efficacy of zanubrutinib in acalabrutinib-intolerant patients with b-cell malignancies
-
9:03
brukinsa® (zanubrutinib): meet wendy, a patient with cll
-
3:19
zanubrutinib and acalabrutinib for cll: potential alternatives to ibrutinib?
-
2:57
selecting between ibrutinib, acalabrutinib and zanubrutinib in the frontline setting in cll